SMTL ID : 5ugd.1

Protease Inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.38 Å

Oligo State

monomer

Ligands

1 x 89S: Nalpha-[trans-4-(aminomethyl)cyclohexane-1-carbonyl]-N-octyl-O-[(pyridin-4-yl)methyl]-L-tyrosinamide(Non-covalent)

89S.1: 17 residues within 4Å: Chain A: T.41, F.47, C.48, H.63, K.67, D.195, S.196, C.197, Q.198, G.199, D.200, S.201, T.219, W.221, G.222, G.224, G.232 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:F.47, A:T.219 Hydrogen bonds: A:K.67, A:S.196, A:G.199, A:D.200, A:S.201, A:S.201 Water bridges: A:F.47, A:S.201, A:V.233

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Law, R.H.P. et al., X-ray crystal structure of plasmin with tranexamic acid-derived active site inhibitors. Blood Adv (2017)

Release Date

2017-05-31

Peptides

Plasminogen: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Plasminogen

Related Entries With Identical Sequence